Home Others Others Pyrimidine

research use only

Pyrimidine

Cat.No.E4265

Pyrimidine is an endogenous metabolite. It is used to study the photoinduced ion chemistry of the halogenated pyrimidines, a class of prototype radiosensitizing molecules, and is also used to assess pyrimidine/purine asymmetry quantitatively.
Pyrimidine Chemical Structure

Chemical Structure

Molecular Weight: 80.09

Jump to Mechanism of Action Chemical Information, Storage & Stability

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 80.09 Formula

C4H4N2

 Storage (From the date of receipt) 2 years  -20°C  liquid
CAS No. 289-95-2 Download SDF Storage of Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05307289 Recruiting
Melanoma (Skin)
Centre Hospitalier Universitaire de Nice
 May 25 2022 Not Applicable
NCT05926791 Completed
Sun Damaged Skin
Pierre Fabre Dermo Cosmetique
 June 28 2021 --
NCT04654312 Completed
Photosensitivity
Universität des Saarlandes
 January 18 2021 Phase 1
NCT00216021 Completed
Metastatic Breast Cancer
Hoosier Cancer Research Network|Sanofi|Hoffmann-La Roche|Walther Cancer Institute
 March 2004 Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.